L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	203.40B +41.9%
Revenue (ttm)	38.92B +7.8%
Net Income	-16.30B
EPS	-802.00
Shares Out	22.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	198,516
Average Volume	379,044
Open	9,190.00
Previous Close	9,350.00
Day's Range	9,000.00 - 9,290.00
52-Week Range	5,570.00 - 16,400.00
Beta	0.72
RSI	30.20
Earnings Date	Mar 26, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 101
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100